Saffron Hill Ventures

Saffron Hill Ventures is a London-based venture capital firm that specializes in early-stage investments within the technology, clean energy, and life sciences sectors. Founded in 2000, the firm focuses on European start-ups with high growth potential and disruptive technologies. In the healthcare space, they have historically backed companies involved in medical devices, diagnostics, and digital health, such as the molecular diagnostics company Agendia. The firm provides not only capital but also strategic guidance and access to an extensive international network to help portfolio companies scale. Saffron Hill typically acts as a lead or co-lead investor, taking an active role in the development of its portfolio businesses.